Scholar Rock Holding Corporation | Mid-cap | Healthcare
$35.42
-1.09%
| Scholar Rock Holding Stock Comparison:
Scholar Rock Holding vs VertexScholar Rock Holding vs RegeneronScholar Rock Holding vs Blueprint MedicinesScholar Rock Holding vs Roivant SciencesScholar Rock Holding vs Bio-TechneScholar Rock Holding vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 0
Operating Income -252.1M
Net Income -246.3M

Balance Sheet Metrics

Total Assets 474.9M
Total Liabilities 106.3M
Shareholders Equity 368.6M
Debt to Equity 0.29

Cash Flow Metrics

Operating Cash Flow -200.5M
Free Cash Flow -201.0M

Revenue & Profitability Trend

Scholar Rock Holding Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 0 0 33.2M 18.8M 15.4M
Cost of Goods Sold - - - - -
Gross Profit - - - - -
Operating Expenses 252.1M 171.3M 167.6M 148.7M 102.3M
Operating Income -252.1M -171.3M -134.4M -129.9M -86.9M
Pre-tax Income -246.3M -165.8M -134.5M -131.8M -86.5M
Income Tax - - - - -
Net Income -246.3M -165.8M -134.5M -131.8M -86.5M
EPS (Diluted) - -$1.99 -$2.26 -$3.59 -$2.81

Income Statement Trend

Scholar Rock Holding Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 451.2M 288.2M 328.0M 265.3M 344.4M
Non-Current Assets 23.8M 22.8M 30.1M 39.1M 43.9M
Total Assets 474.9M 311.0M 358.2M 304.4M 388.3M
Liabilities
Current Liabilities 46.9M 32.7M 36.4M 64.3M 42.6M
Non-Current Liabilities 59.4M 53.1M 61.5M 68.1M 85.0M
Total Liabilities 106.3M 85.8M 97.9M 132.4M 127.5M
Equity
Total Shareholders Equity 368.6M 225.2M 260.2M 172.1M 260.8M

Balance Sheet Composition

Scholar Rock Holding Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -246.3M -165.8M -134.5M -131.8M -86.5M
Operating Cash Flow -200.5M -139.6M -137.2M -122.9M -61.9M
Investing Activities
Capital Expenditures -98.0K -58.0K -1.1M -5.2M -4.1M
Investing Cash Flow -76.1M 41.1M -171.7M 134.3M -63.5M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 324.3M 97.7M 193.4M 38.1M 240.5M
Free Cash Flow -201.0M -145.3M -133.8M -132.0M -64.4M

Cash Flow Trend

Scholar Rock Holding Key Financial Ratios

Valuation Ratios

Forward P/E -15.48
Price to Book 10.11
PEG Ratio -15.48

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity -106.71%
Return on Assets -50.15%

Financial Health

Current Ratio 10.25
Debt to Equity 20.22
Beta 0.30

Per Share Data

EPS (TTM) -$2.55
Book Value per Share $3.29

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
srrk 3.2B - 10.11 -106.71% 0.00% 20.22
Vertex 114.1B 32.82 6.92 -5.64% -8.91% 10.00
Regeneron 55.3B 13.02 1.84 15.96% 31.94% 9.20
Blueprint Medicines 8.3B -120.00 24.19 -47.71% -27.70% 208.50
Roivant Sciences 7.8B 1.95 1.71 -12.54% 96.86% 1.93
Bio-Techne 7.9B 60.87 3.92 6.53% 10.89% 20.99

Financial data is updated regularly. All figures are in the company's reporting currency.